2X-121 Uses, Dosage, Side Effects and more
2X-121 is under investigation in clinical trial NCT03562832 (Investigation of Anti-tumour Effect and Tolerability of the PARP Inhibitor 2X-121 in Patients With Metastatic Breast Cancer Selected by the 2X-121 DRP).
| Trade Name | 2X-121 |
| Generic | 2X-121 |
| Type | |
| Formula | C18H15N5O |
| Weight | Average: 317.352 Monoisotopic: 317.127660123 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
